News & Updates
Filter by Specialty:
RSV may worsen clinical outcomes in HF patients
A retrospective analysis presented at HSFA ASM 2024 shows that respiratory syncytial virus (RSV) infection in individuals with heart failure (HF) is associated with greater adverse clinical outcomes.
RSV may worsen clinical outcomes in HF patients
01 Nov 2024
Sacubitril/valsartan maintains efficacy, safety in HF patients with hypotension
Both symptomatic and asymptomatic hypotension are associated with worse outcomes during treatment with either enalapril or sacubitril/valsartan, but the benefits derived from the combination therapy are maintained or even improved in heart failure (HF) patients with hypotension, a study has shown.
Sacubitril/valsartan maintains efficacy, safety in HF patients with hypotension
31 Oct 2024
Aficamten improves clinical outcomes in obstructive HCM
Patients with obstructive hypertrophic cardiomyopathy (oHCM) can derive broad clinical benefits from treatment with aficamten, which include complete haemodynamic response and improved exercise capacity among others, as shown by the results of the SEQUOIA-HCM study.
Aficamten improves clinical outcomes in obstructive HCM
30 Oct 2024
Door-to-balloon time can be more lenient in STEMI not complicated by cardiogenic shock
A longer DTBT of up to 180 min is not associated with worse clinical outcomes at 30 days and 1 year in patients with STEMI presenting in Killip classes I–III, according to an analysis of data from the Singapore Myocardial Infarction Registry
Door-to-balloon time can be more lenient in STEMI not complicated by cardiogenic shock
30 Oct 2024
Beta blocker adjustment shows no impact on tachyarrhythmias in admitted HFrEF patients
Holding or decreasing the dose of outpatient beta blocker therapy does not seem to affect the incidence of tachyarrhythmias in patients with heart failure with reduced ejection fraction (HFrEF) admitted for acute decompensated heart failure (ADHF), reports a study.